THRB Genetic Polymorphisms Can Predict Severe Myelotoxicity after Definitive Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma

Objective: Chemotherapy-related toxicities are difficult to predict before treatment. In this study, we investigated whether thyroid hormone receptor beta (THRB) genetic polymorphisms can serve as a potential biomarker in patients with esophageal squamous cell carcinoma (ESCC). Methods: Forty-nine J...

Descripción completa

Detalles Bibliográficos
Autores principales: Miki, Ikuya, Nakamura, Tsutomu, Kuwahara, Akiko, Yamamori, Motohiro, Nishiguchi, Kohshi, Tamura, Takao, Okuno, Tatsuya, Omatsu, Hideaki, Mizuno, Shigeto, Hirai, Midori, Azuma, Takeshi, Sakaeda, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491433/
https://www.ncbi.nlm.nih.gov/pubmed/23136537
http://dx.doi.org/10.7150/ijms.5081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491433/
https://www.ncbi.nlm.nih.gov/pubmed/23136537
http://dx.doi.org/10.7150/ijms.5081

Ejemplares similares